Why I Oppose New Cosmetics Laws That Do Not Contain Exemptions For Small Businesses
Last week, I shared plans to return to Washington, DC on a fact-finding mission with regard to the FDA Globalization Act of 2009 (FDAG 2009). If you have not done so, please read that post for background and context. This post provides a high level overview of what I learned on that trip. (If you…